P420Can we measure carotid plaque volume and does it matter?

    loading  Checking for direct PDF access through Ovid

Abstract

Stroke is the third leading cause of death and the leading cause of disability with 150,000 sufferers/year in the UK. Carotid disease causes 30% of ischaemic strokes, probably due to embolism of atherosclerotic material. Severity of stenosis measured by duplex is currently the indication for surgery but is a poor predictor of stroke: asymptomatic carotid stenosis >70% predicts an annual stroke risk of under 2%. As stenoses may merely be a surrogate for carotid plaque volume (CPV), we investigated the relationship between CPV and symptoms in carotid disease.

Plaque volume index on preoperative duplex was compared with a precise measure of the operative specimen using an Archimedes suspension method in 52 patients undergoing carotid endarterectomy. A detailed history on risk factors and cerebral symptoms was recorded.

Plaque volume index underestimated CPV by mean ( ± sd) of 0.41 ± 0.49cm3 with a poor correlation of r = 0.49 (p < 0.05). Mean CPV for stroke, TIA, amaurosis fugax and asymptomatic patients were 1.26 ± 0.65, 1.20 ± 0.52, 1.16 ± 0.25and 0.75 ± 0.27cm3 respectively with the 36 symptomatic having significantly larger CPV at 1.21 ± 0.56cm3 than that of 0.79 ± 0.26cm3 in the 16 asymptomatic patients (p>0.01). Acutely symptomatic patients had significantly larger CPV with a mean of 1.32 ± 0.54cm3 than that of asymptomatic and symptomatic patients of more than six weeks with a mean of 0.74 ± 0.28 and 0.76 ± 0.2cm3 respectively.

CPV can be measured accurately using an Archimedes suspension method and was strongly associated with symptoms in patients undergoing carotid surgery. As all our patients had >70% carotid stenoses, CPV clearly has greater potential to predict symptom status. If 3-D imaging measures CPV accurately, the indication for carotid surgery may need to be reconsidered.

Related Topics

    loading  Loading Related Articles